TipRanks
Advertisement
Advertisement
Neurocrine price target lowered to $165 from $190 at Deutsche Bank
PremiumThe FlyNeurocrine price target lowered to $165 from $190 at Deutsche Bank
1M ago
Neurocrine price target lowered to $182 from $196 at Morgan Stanley
Premium
The Fly
Neurocrine price target lowered to $182 from $196 at Morgan Stanley
1M ago
Neurocrine price target lowered to $218 from $221 at Bernstein
Premium
The Fly
Neurocrine price target lowered to $218 from $221 at Bernstein
1M ago
Neurocrine Biosciences Earnings Call Signals Scaled Growth
PremiumCompany AnnouncementsNeurocrine Biosciences Earnings Call Signals Scaled Growth
2M ago
Neurocrine price target raised to $249 from $246 at Citi
Premium
The Fly
Neurocrine price target raised to $249 from $246 at Citi
2M ago
Neurocrine Biosciences: Strong Q2 Execution, Expanded Pipeline, and Multi-Billion-Dollar Peak Sales Potential Support Buy Rating
Premium
Ratings
Neurocrine Biosciences: Strong Q2 Execution, Expanded Pipeline, and Multi-Billion-Dollar Peak Sales Potential Support Buy Rating
2M ago
Neurocrine price target raised to $214 from $199 at BofA
PremiumThe FlyNeurocrine price target raised to $214 from $199 at BofA
2M ago
Neurocrine price target raised to $215 from $210 at Cantor Fitzgerald
Premium
The Fly
Neurocrine price target raised to $215 from $210 at Cantor Fitzgerald
2M ago
Neurocrine price target raised to $204 from $200 at Needham
Premium
The Fly
Neurocrine price target raised to $204 from $200 at Needham
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100